Anti-Myelin oligodendrocyte glycoprotein 抗体 [EP4281]
Anti-Myelin oligodendrocyte glycoprotein antibody [EP4281] - Oligodendrocyte Marker
- RabMAb
- Recombinant
- 詳細を見る
4
(6 Reviews)
|
(23 Publications)
Rabbit Recombinant Monoclonal Myelin oligodendrocyte glycoprotein antibody. Suitable for WB, IHC-P and reacts with Mouse, Rat, Human samples. Cited in 23 publications.
別名を表示する
Myelin-oligodendrocyte glycoprotein, MOG
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Myelin oligodendrocyte glycoprotein antibody [EP4281] - Oligodendrocyte Marker (AB109746)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human cerebrum tissue sections labeling Myelin oligodendrocyte glycoprotein with purified ab109746 at 1 : 1000 dilution (1.12 μg/ml). Heat mediated antigen retrieval was performed using ab93684 (Tris/EDTA buffer, pH 9.0). Tissue was counterstained with Hematoxylin. ImmunoHistoProbe one step HRP Polymer (ready to use). PBS instead of the primary antibody was used as the negative control.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Myelin oligodendrocyte glycoprotein antibody [EP4281] - Oligodendrocyte Marker (AB109746)
ab109746 showing negative staining in Normal colon tissue. This image was produced using unpurified antibody.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Myelin oligodendrocyte glycoprotein antibody [EP4281] - Oligodendrocyte Marker (AB109746)
ab109746 showing negative staining in Breast carcinoma tissue. This image was produced using unpurified antibody.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Myelin oligodendrocyte glycoprotein antibody [EP4281] - Oligodendrocyte Marker (AB109746)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human astrocytoma tissue sections labeling Myelin oligodendrocyte glycoprotein with purified ab109746 at 1 : 1000 dilution (1.12 μg/ml). Heat mediated antigen retrieval was performed using ab93684 (Tris/EDTA buffer, pH 9.0). Tissue was counterstained with Hematoxylin. ImmunoHistoProbe one step HRP Polymer (ready to use). PBS instead of the primary antibody was used as the negative control.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Myelin oligodendrocyte glycoprotein antibody [EP4281] - Oligodendrocyte Marker (AB109746)
ab109746 showing negative staining in Normal breast tissue. This image was produced using unpurified antibody.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Myelin oligodendrocyte glycoprotein antibody [EP4281] - Oligodendrocyte Marker (AB109746)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of rat cerebrum tissue sections labeling Myelin oligodendrocyte glycoprotein with purified ab109746 at 1 : 1000 dilution (1.12 μg/ml). Heat mediated antigen retrieval was performed using ab93684 (Tris/EDTA buffer, pH 9.0). Tissue was counterstained with Hematoxylin. ImmunoHistoProbe one step HRP Polymer (ready to use). PBS instead of the primary antibody was used as the negative control.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Myelin oligodendrocyte glycoprotein antibody [EP4281] - Oligodendrocyte Marker (AB109746)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of mouse cerebrum tissue sections labeling Myelin oligodendrocyte glycoprotein with Purified ab109746 at 1 : 1000 dilution (1.12 μg/ml). Heat mediated antigen retrieval was performed using ab93684 (Tris/EDTA buffer, pH 9.0). Tissue was counterstained with Hematoxylin. ImmunoHistoProbe one step HRP Polymer (ready to use) secondary antibody was used at 1 : 0 dilution. PBS instead of the primary antibody was used as the negative control.
- WB
Lab
Western blot - Anti-Myelin oligodendrocyte glycoprotein antibody [EP4281] - Oligodendrocyte Marker (AB109746)
Blocking buffer concentrations : 5% NFDM/TBST
Diluting buffer concentrations : 5% NFDM/TBST
Exposure equipment : iBright CL 1000 Imaging System
All lanes:
Western blot - Anti-Myelin oligodendrocyte glycoprotein antibody [EP4281] - Oligodendrocyte Marker (ab109746) at 1/1000 dilution
All lanes:
Human brain tissue lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/2000 dilution
Predicted band size: 28 kDa
Observed band size: 25 kDa,15 kDa
true
Exposure time: 3s
- WB
Lab
Western blot - Anti-Myelin oligodendrocyte glycoprotein antibody [EP4281] - Oligodendrocyte Marker (AB109746)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
The bands beneath the target band (25 kDa) are likely to be degraded target fragments.
In lanes 1-2, to minimize protein degradation, cells were lysed immediately after harvest and then applied to a gel and transfer membrane for Western blotting as soon as possible.
In lanes 3-4, this blot was developed using a high sensitivity ECL substrate. The high-sensitivity ECL substrate used allows for the detection of proteins in the mid-femtogram range.
Exposure time :
Lanes 1-2 : 180 seconds,
Lanes 3-4 : 92 seconds.
Exposure equipment : iBright CL 1000 Imaging System.
All lanes:
Western blot - Anti-Myelin oligodendrocyte glycoprotein antibody [EP4281] - Oligodendrocyte Marker (ab109746) at 1/1000 dilution
Lanes 1 and 3:
Mouse brain tissue lysate at 20 µg
Lanes 2 and 4:
Rat brain tissue lysate at 20 µg
Secondary
Lanes 1 - 2:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Lanes 3 - 4:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 28 kDa
Observed band size: 25 kDa,15 kDa
true
- WB
Lab
Western blot - Anti-Myelin oligodendrocyte glycoprotein antibody [EP4281] - Oligodendrocyte Marker (AB109746)
Exposure time : Lane 1-3&5-7 : 20 seconds; Lane 4&8 : 180 seconds
In Western blot analysis, ab109746 exhibited lower sensitivity compared to ab108505 and ab233549, for which reason we recommend the latter two as superior alternatives
Protocol optimizations including increased protein loading (30-50 μg/lane), reduced primary antibody dilution (1 : 500), and fg-grade ECL substrates are suggested if ab109746 must be used.
Lanes 1, 4, 5 and 8:
Western blot - Anti-Myelin oligodendrocyte glycoprotein antibody [EP4281] - Oligodendrocyte Marker (ab109746) at 1/1000 dilution
Lanes 2 and 6:
Western blot - Anti-Myelin oligodendrocyte glycoprotein antibody [EPR4282] - Oligodendrocyte Marker (<a href='/products/primary-antibodies/myelin-oligodendrocyte-glycoprotein-antibody-epr4282-oligodendrocyte-marker-ab108505'>ab108505</a>) at 1/1000 dilution
Lanes 3 and 7:
Western blot - Anti-Myelin oligodendrocyte glycoprotein antibody [EPR22629-310] - Oligodendrocyte Marker (<a href='/products/primary-antibodies/myelin-oligodendrocyte-glycoprotein-antibody-epr22629-310-oligodendrocyte-marker-ab233549'>ab233549</a>) at 1/1000 dilution
Lanes 1 - 4:
Mouse brain tissue lysate at 20 µg
Lanes 5 - 8:
Rat brain tissue lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 25 kDa
false
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Myelin oligodendrocyte glycoprotein antibody [EP4281] - Oligodendrocyte Marker (AB109746)
ab109746 showing negative staining in Benign prostatic hyperplasia tissue. This image was produced using unpurified antibody.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Myelin oligodendrocyte glycoprotein antibody [EP4281] - Oligodendrocyte Marker (AB109746)
ab109746 showing negative staining in Colonic adenocarcinoma tissue. This image was produced using unpurified antibody.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Myelin oligodendrocyte glycoprotein antibody [EP4281] - Oligodendrocyte Marker (AB109746)
ab109746 showing negative staining in Normal tonsil tissue. This image was produced using unpurified antibody.
- WB
CiteAb
Western blot - Anti-Myelin oligodendrocyte glycoprotein antibody [EP4281] - Oligodendrocyte Marker (AB109746)
Myelin oligodendrocyte glycoprotein western blot using anti-Myelin oligodendrocyte glycoprotein antibody [EP4281] ab109746. Publication image and figure legend from Hoban, A. E., Stilling, R. M., et al., 2016, Transl Psychiatry, PubMed 27045844.
ab109746 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab109746 please see the product overview.
Increased myelin protein in male germ-free (GF) and exGF mice. (a) Western blot analysis for MOG in the prefrontal cortex (PFC) of conventional (CON), GF and exGF. (b) Quantification of protein concentration was normalized to β-III-tubulin and expressed relative to control levels. (c) Schematic representation of findings highlighting the transcriptional network driving increased myelination. Bar graph data is shown as mean±s.e.m. *p<0.05; **p<0.01.
false
関連する標識済み抗体及び組成の異なる製品 (3)
-
Anti-Myelin oligodendrocyte glycoprotein antibody [EP4281] - BSA and Azide free
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-Myelin oligodendrocyte glycoprotein antibody [EP4281] - Oligodendrocyte Marker
-
HRP Anti-Myelin oligodendrocyte glycoprotein antibody [EP4281] - Oligodendrocyte Marker
Reactivity data
製品の詳細
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
出荷温度及び保存条件
製品の状態
精製方法
バッファー組成
出荷温度
短期保存期間
短期保存温度
長期保存温度
分注に関する情報
保管に関する情報
補足情報
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
MOG influences the immune response and possibly adhesion between myelin membranes. Although it does not form part of a larger well-defined complex it may interact with other myelin-associated proteins to contribute to myelin construction and maintenance. MOG's involvement in these processes supports myelin sheath formation and function aiding electrical conduction in nerve cells. The protein's exposure on the myelin membrane makes it a possible target for immune attacks hinting at its role in autoimmunity.
Pathways
MOG is involved in immune responses and central nervous system pathways. One significant pathway is the autoimmune pathway where MOG can engage with or be targeted by autoimmune antibodies. It interacts with other proteins like myelin basic protein (MBP) in maintaining myelin structures and influencing immunological functions. This interaction implies that disturbances in these pathways might contribute to numerous neurological disorders.
製品プロトコール
- Visit the General protocols
- Visit the Troubleshooting
ターゲットの情報
文献 (23)
Recent publications for all applications. Explore the full list and refine your search
Annals of neurology 97:313-328 PubMed39422285
2024
Applications
Unspecified application
Species
Unspecified reactive species
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 21:e00432 PubMed39164165
2024
Applications
Unspecified application
Species
Unspecified reactive species
Neurology(R) neuroimmunology & neuroinflammation 11:e200249 PubMed38696737
2024
Applications
Unspecified application
Species
Unspecified reactive species
Nature neuroscience 26:1218-1228 PubMed37386131
2023
Applications
Unspecified application
Species
Unspecified reactive species
JCI insight 8: PubMed37097758
2023
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 23: PubMed35955811
2022
Applications
Unspecified application
Species
Unspecified reactive species
Neural regeneration research 18:404-409 PubMed35900437
2022
Applications
Unspecified application
Species
Unspecified reactive species
Developmental neuroscience 44:91-101 PubMed34986480
2022
Applications
Unspecified application
Species
Unspecified reactive species
Neurobiology of disease 162:105567 PubMed34838669
2021
Applications
Unspecified application
Species
Unspecified reactive species
Cancer letters 466:1-12 PubMed31521694
2019
Applications
Unspecified application
Species
Unspecified reactive species
Abcam product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com